Clincosm LogoSign in Get a demo

Lymphoma

Showing NaN - NaN of 239
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Non-Hodgkin, Hodgkin Lymphoma Trial in Worldwide (AZD3470)

Not yet recruiting
  • Lymphoma
  • +2 more
  • Miami, Florida
  • +10 more
Nov 13, 2023

Lymphoma Trial in Houston (PCV20)

Not yet recruiting
  • Lymphoma
  • PCV20
  • Houston, Texas
    M D Anderson Cancer Center
Sep 20, 2023

Advanced Solid Tumors, Lymphoma, Gastric Cancer Trial in United States (FT500, Nivolumab, Pembrolizumab)

Completed
  • Advanced Solid Tumors
  • +17 more
  • San Diego, California
  • +3 more
Jan 27, 2023

Lymphoma, Multiple Myeloma, Acute Myeloid Leukemia Trial in United States (TTI-622, Azacitidine, Venetoclax)

Recruiting
  • Lymphoma
  • +3 more
  • Los Angeles, California
  • +36 more
Jan 23, 2023

Solid Tumor, Lymphoma Trial in Israel, United States (MK-2118 (IT), MK-2118 (SC), Pembrolizumab)

Completed
  • Solid Tumor
  • Lymphoma
  • MK-2118 (IT)
  • +2 more
  • La Jolla, California
  • +7 more
Jan 23, 2023

Leukemia, Lymphoma Trial in United States (SCRI-CAR22v2)

Recruiting
  • Leukemia
  • Lymphoma
  • SCRI-CAR22v2
  • Los Angeles, California
  • +4 more
Jan 18, 2023

Lymphoma Trial in Houston (Rituximab, Lenalidomide, Valemetostat)

Not yet recruiting
  • Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Jan 4, 2023

Lymphoma Trial in Worldwide (HMPL-689)

Active, not recruiting
  • Lymphoma
  • Anaheim, California
  • +26 more
Jan 11, 2023

Lymphoma Trial in Houston (cell-free DNA)

Not yet recruiting
  • Lymphoma
  • cell-free DNA
  • Houston, Texas
    MD Anderson Cancer Center
Dec 22, 2022

Lymphoma, HIV Trial in United States (Autologous transplant, BCNU, Etoposide)

Completed
Has Results
  • Lymphoma
  • HIV
  • Autologous transplant
  • +4 more
  • Duarte, California
  • +15 more
Dec 6, 2022

Leukemia, Lymphoma Trial in Houston (Ofatumumab)

Active, not recruiting
  • Leukemia
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 9, 2022

Lymphoma Trial in Houston (Radiation Therapy, Dexamethasone, Etoposide phosphate)

Recruiting
  • Lymphoma
  • Radiation Therapy
  • +5 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 9, 2022

Tumors, Lymphoma, Hematologic Tumors Trial in Ukraine, United States (TAK-981)

Recruiting
  • Neoplasms
  • +2 more
  • La Jolla, California
  • +15 more
Dec 7, 2022

Lymphoma, Leukemia Trial in United States (CPI-613)

Recruiting
  • Lymphoma
  • Leukemia
  • Duarte, California
  • +9 more
Nov 28, 2022

Solid Tumors, Lymphoma Trial in Worldwide (ASTX660)

Active, not recruiting
  • Solid Tumors
  • Lymphoma
  • Birmingham, Alabama
  • +68 more
Nov 18, 2022

CB-Long-Term Safety Study (CB-LTSS)

Enrolling by invitation
  • Lymphoma, Non-Hodgkin
  • +7 more
  • Allogeneic CAR-T therapy
  • Irvine, California
  • +3 more
Nov 18, 2022

Lymphoma Trial in United States (itacitinib, ibrutinib)

Completed
  • Lymphoma
  • Scottsdale, Arizona
  • +20 more
Nov 14, 2022

Metastatic Cancer, Solid Tumor, Lymphoma Trial in Canada, United States (Sym021, Sym022, Sym023)

Completed
  • Metastatic Cancer
  • +2 more
  • Grand Rapids, Michigan
  • +3 more
Oct 25, 2022

Leukemia, Lymphoma Trial in Houston (Rituximab, Lenalidomide)

Active, not recruiting
  • Leukemia
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 11, 2022

Lymphoma Trial in Houston (Ibritumomab Tiuxetan (Zevalin), Rituximab)

Completed
Has Results
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 30, 2022

Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma Trial in United States (CB-010,

Recruiting
  • Lymphoma, Non-Hodgkin
  • +6 more
  • CB-010
  • +2 more
  • Scottsdale, Arizona
  • +7 more
Aug 19, 2022

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Lymphoma, Nonneoplastic Condition Trial in United States (bleomycin sulfate, filgrastim, ABVD regimen)

Completed
Has Results
  • Lymphoma
  • Nonneoplastic Condition
  • bleomycin sulfate
  • +11 more
  • Tucson, Arizona
  • +422 more
Aug 16, 2022

Locally Advanced Solid Tumors, Metastatic Solid Tumors, Lymphoma Trial in Worldwide (Oral repotrectinib (TPX-0005))

Recruiting
  • Locally Advanced Solid Tumors
  • +3 more
  • Oral repotrectinib (TPX-0005)
  • Los Angeles, California
  • +27 more
Aug 9, 2022

Lymphoma, Mantle Cell Lymphoma Trial in Houston (Acalabrutinib, Rituximab, Brexucabtagene Autoleucel)

Not yet recruiting
  • Lymphoma
  • Mantle Cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Aug 10, 2022